Beta Bionics, Inc. 2026 Annual Meeting of Stockholders

On May 21, 2026, Beta Bionics, Inc. held its 2026 Annual Meeting of Stockholders. The meeting included two proposals: the election of directors and the ratification of the appointment of an independent registered public accounting firm. Two Class I directors, Sean D. Carney and Christy Jones, were elected. The appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified. A quorum of 36,061,048 shares of common stock was represented. The election of directors saw significant votes in favor, with Sean D. Carney receiving 30,659,060 votes for and Christy Jones receiving 25,865,542 votes for. The ratification of Ernst & Young LLP as the accounting firm received 36,011,432 votes for.